Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-09-22 Sale | 2020-09-24 4:19 pm | AKCEA THERAPEUTICS INC. | AKCA | McDevitt Damien Chief Executive Officer | 8,709 | $18.12 | $157,807 | 242,978 (Direct) | View |
2020-03-23 Sale | 2020-03-25 4:41 pm | AKCEA THERAPEUTICS INC. | AKCA | McDevitt Damien Chief Executive Officer | 9,417 | $11.75 | $110,649 | 245,783 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2020-10-12 Equity Swap | 2020-10-13 3:54 pm | N/A N/A | AKCEA THERAPEUTICS INC. | AKCA | McDevitt Damien Chief Executive Officer | 242,978 | $18.15 | 0 (Direct) | View |
2020-10-12 Disposition | 2020-10-13 3:54 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS INC. | AKCA | McDevitt Damien Chief Executive Officer | 320,000 | $5.39 | 0 (Direct) | View |
2020-08-31 Option Award | 2020-09-02 4:20 pm | N/A N/A | AKCEA THERAPEUTICS INC. | AKCA | McDevitt Damien Chief Executive Officer | 1,104 | $14.4 | 251,687 (Direct) | View |
2020-03-19 Option Award(A) | 2020-03-31 8:41 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS INC. | AKCA | McDevitt Damien Chief Executive Officer | 180,000 | $0 | 380,000 (Direct) | View |
2020-03-19 Option Award | 2020-03-23 4:22 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS INC. | AKCA | McDevitt Damien Chief Executive Officer | 365,000 | $0 | 565,000 (Direct) | View |